Randomized, placebo‐controlled, double‐blind phase I trial of co‐administered pyronaridine and piperaquine in healthy adults of sub‐Saharan origin

Abstract Drug resistance to sulfadoxine‐pyrimethamine and amodiaquine threatens the efficacy of malaria chemoprevention interventions in children and pregnant women. Combining pyronaridine (PYR) and piperaquine (PQP), both components of approved antimalarial therapies, has the potential to protect v...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Andrea Kuemmerle, Denis Gossen, Annick Janin, Andrew Stokes, Nada Abla, Maja Szramowska, Ulrike Lorch, Myriam El Gaaloul, Isabelle Borghini‐Fuhrer, Stephan Chalon
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2024-04-01
Sarja:	Clinical and Translational Science
Linkit:	https://doi.org/10.1111/cts.13738
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!